This study, in addition, strongly suggested that Trem2‐Igf1 signaling axis orchestrated this microglial phenotype shift during ischemic stroke, and immunometabolism underlying microglial transformation could be pharmacologically or genetically modulated. The gene discussed is IGF1; the disease is ischemic stroke.